EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. – Apellis Pharmaceuticals, Inc. Transaction History
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. portfolio value:
$1.86M
portfolio value
EFG ASSET MANAGEMENT (NORTH AMERICA) CORP. quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -37.39% | -16.32K shares | -109K | $68.3 | 27.33K |
| Q2 2022 | share | Decrease | -22.81% | -12.89K shares | -898K | $45.22 | 43.65K |
| Q1 2022 | share | Decrease | -0.89% | -505 shares | 171K | $50.81 | 56.55K |
| Q4 2021 | share | Increase | 0.00% | 57.05K shares | 2.70M | $47.95 | 57.05K |